Serplulimab
Drug timelines are a Plus or Pro feature.
80 regulatory and trial events tracked for Serplulimab, covering 2022-07-05 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer [Phase 2]